Work

Microbiological profile of slow-growing non-tuberculous mycobacteria species other than Mycobacterium avium complex

Year: 2025
Type: article
Study design: Observational Study
Abstract: Introduction Mycobaterium avium complex (MAC) and Mycobacterium abscessus complex are the primary agents of non-tuberculous mycobacteria infection. However, other species within the slow-growing group can also be potentially pathogenic, although information on these species is limited. Objectives We conducted a prospective analysis of slow-growing species other than MAC, aimed at the identification and microbiological profiles of clinical samples from a tertiary hospital. The Microbiology Department of the Hospital Clinic of Barcelona, the Microbiology Laboratory of SYNLAB Laboratories, and the Microbiology Laboratory of Hospital Sant Joan de Deu participated in the study. Methods Species identification was conducted by MALDI-TOF MS and/or 16S rRNA and rpoB gene sequencing. Drug susceptibility tests (DST) were performed using the microdilution method. The results of the susceptibility profiles were compared with treatment guidelines, or the most recent literature related to each species. Results Twenty-five different species belonging to the slow-growing group were identified. The most frequently observed were M. xenopi, M. kansasii, M. gordonae, and M. marinum. In this series, M. lentiflavum presented the highest susceptibility profile, while M. simiae demonstrated the highest level of resistance. Clarithromycin, rifabutin, and amikacin demonstrated high levels of effectiveness across all species. The species most associated with infection, presented a high correlation with the clinical treatment guidelines. Conclusion A specific susceptibility profile was observed among all the species. The in vitro profiles of the most frequent species correlated with the clinical treatment guidelines, reinforcing the supporting role of DST in the design of individualized treatment for each patient.
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W4409825272
FWCI: 1.869
Cites: 18
Cited by: 3
Related to: 10